Related Experiment Videos
Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants
Abstract:
The metabolism of bioreactive lipid mediators was studied in two types of activated macrophages (M phi). We compared the capacity of resident and activated M phi to release, upon a zymosan challenge, cyclooxygenase and lipoxygenase products as well as PAF-acether (platelet-activating factor) and its 2-lyso precursor. Activated M phi were obtained from mice injected intraperitoneally either with nonviable C74 streptococci (St-M phi) or with trehalose dimycolate, a defined immunostimulant isolated from Mycobacterium tuberculosis (TDM-M phi). Both activated populations exhibited common features: conversion of endogenous [14C]arachidonic acid into prostaglandin E2 and thromboxane A2 rather than into prostaglandin I2 and low biosynthesis of PAF-acether, probably due to an impairment of the acetylation step. However, contrary to St-M phi, TDM-M phi did not display a marked overall reduction of arachidonate metabolism. In addition, as compared to resident M phi, TDM-M phi presented a ratio of thromboxane B2/6-ketoprostaglandin F1 alpha 30-fold higher, a better conversion of leukotriene C to leukotriene D and a higher capacity to release the PAF-acether they synthesize. These macrophages thus seem to be valuable tools for studying the formation of mediators and for determining specific markers of an activated state.
Insights
Activated macrophages (M phi) metabolize lipid mediators differently. Trehalose dimycolate-activated M phi show distinct arachidonate metabolism and enhanced mediator release compared to streptococci-activated M phi.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Macrophages (M phi) are key immune cells involved in inflammatory responses.
- Lipid mediators play crucial roles in regulating immune cell function and inflammation.
- Understanding macrophage activation states is vital for developing targeted immunotherapies.
Purpose of the Study:
- To investigate and compare the metabolism of bioreactive lipid mediators in two distinct types of activated macrophages.
- To analyze the release of cyclooxygenase and lipoxygenase products, and platelet-activating factor (PAF-acether) in resident and activated M phi.
- To identify specific markers associated with macrophage activation states.
Main Methods:
- Activation of mouse macrophages using nonviable C74 streptococci (St-M phi) or trehalose dimycolate (TDM-M phi).
- Zymosan challenge to stimulate lipid mediator release.
- Measurement of endogenous [14C]arachidonic acid conversion into various eicosanoids and PAF-acether.
- Quantification of specific lipid mediators, including prostaglandins, thromboxanes, leukotrienes, and PAF-acether.
Main Results:
- Both activated M phi populations converted arachidonic acid to prostaglandin E2 and thromboxane A2, with low PAF-acether biosynthesis.
- TDM-M phi exhibited less overall reduction in arachidonate metabolism compared to St-M phi.
- TDM-M phi showed a 30-fold higher thromboxane B2/6-ketoprostaglandin F1 alpha ratio, enhanced leukotriene C to D conversion, and greater PAF-acether release capacity.
Conclusions:
- Activated macrophages display distinct patterns of lipid mediator metabolism.
- TDM-M phi represent a valuable model for studying mediator formation and identifying activation markers.
- These findings contribute to understanding macrophage polarization and inflammatory signaling pathways.